Bahram Varjavand, MD
Neuroradiology · Sacramento, CANPI 1134126501
Payments from drug & device makers
What this record shows
11 manufacturers reported payments, led by Medtronic at 43.0% of the total. Reporting peaked in 2021 at $2,247 and has fallen 75.4% since, to $553 in 2025.
Across 50 payments — averaging $104.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Stryker$2K
- Route 92 Medical, Inc.$322
- Imperative Care, Inc$282
- Microvention, Inc.$167
- Phenox Inc.$141
- plus $198 from 5 others
Across 9 payments — averaging $26,356 each. An ownership or investment interest held by the physician or an immediate family member.
- Scientia Vascular$223K
- Shape Memory Medical Inc.$14K
What the payments were for
- Travel & lodging$2,95257%
- Food & beverage$2,27043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 19 | $2,244 |
| Stryker | 16 | $1,868 |
| Route 92 Medical, Inc. | 2 | $322 |
| Imperative Care, Inc | 5 | $282 |
| Microvention, Inc. | 2 | $167 |
| Phenox Inc. | 1 | $141 |
| Johnson & Johnson | 1 | $77 |
| Qapel Medical Inc | 1 | $38 |
| Scientia Vascular | 1 | $37 |
| Shockwave Medical, Inc | 1 | $25 |
| Cook Medical LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,222 in reported general payments places this provider in the 70th percentile of 154 neuroradiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prasugrel Hcl | 26 | $986 |
| ClopidogrelClopidogrel Bisulfate | 44 | $338 |
| Pantoprazole Sodium | 38 | $223 |
Paid to pharmacies, not to this prescriber.
Other neuroradiology in Sacramento
- Thymur ChaudhrySacramento$36K
- Jonathan HartmanSacramento$5K
- Lotfi Hacein-BeySacramento$4K
- Matthew BobinskiSacramento$3K
- Azad GhassemiSacramento$1K
- Aaron BerezMountain View$24.1M
- Amon LiuRedwood City$1.1M
- Fabio SettecaseSan Francisco$758K
- Michael MarksStanford$254K
- Huy DoStanford$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.